Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro-Reference-Cited by-同舟云学术

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro

Published:1999-03 Issue:6 Volume:57 Page:697-703
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Suzumura Kuniharu,Yasuhara Mikiko,Tanaka Keiko,Suzuki Toshikazu

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference31 articles.

1. Fluvastatin;Plosker;Drugs,1996

2. Brown WV, (Ed.), A symposium: Hydroxymethylglutaryl coenzyme A reductase inhibition: Fluvastatin, a clinical investigators’ update. Am J Cardiol73: 1D–61D, 1994.

3. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition;Goldstein;Proc Natl Acad Sci USA,1979

4. Factors regulating the activity of the low density lipoprotein receptor and scavenger receptor on human monocyte-macrophages;Forgelman;J Lipid Res,1981

5. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits;Haberland;Science,1988

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous quantification of two commonly used anticoagulant drugs and three hypolipidemic drugs in human plasma using gradient high-performance liquid chromatography;Journal of Liquid Chromatography & Related Technologies;2024-07-31

2. Oxidants and Endothelial Dysfunction;Reference Module in Biomedical Sciences;2024

3. Understanding the molecular mechanisms of statin pleiotropic effects;Archives of Toxicology;2023-04-21

4. Association between Oxidative Burden and Restenosis: A Case-Control Study;Oxidative Medicine and Cellular Longevity;2022-06-28

5. The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials;Cureus;2021-09-19